These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16988445)

  • 1. A stress protein-facilitated antigen expression system for plasmid DNA vaccines.
    Riedl P; Fissolo N; Reimann J; Schirmbeck R
    Methods Mol Med; 2006; 127():41-53. PubMed ID: 16988445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccines expressing antigens with a stress protein-capturing domain display enhanced immunogenicity.
    Reimann J; Schirmbeck R
    Immunol Rev; 2004 Jun; 199():54-67. PubMed ID: 15233726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming polyvalent immunity by DNA vaccines expressing chimeric antigens with a stress protein-capturing, viral J-domain.
    Schirmbeck R; Kwissa M; Fissolo N; Elkholy S; Riedl P; Reimann J
    FASEB J; 2002 Jul; 16(9):1108-10. PubMed ID: 12039856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen.
    Schirmbeck R; Reimann J
    Biol Chem; 2001 Apr; 382(4):543-52. PubMed ID: 11405219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction, expression and immunoassay detection of recombinant plasmid encoding fusion protein of Roman chicken complement C3d and Newcastle disease virus F gene.
    Liu D; Niu ZX
    Scand J Immunol; 2008 Dec; 68(6):598-606. PubMed ID: 19055698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection.
    Brulet JM; Maudoux F; Thomas S; Thielemans K; Burny A; Leo O; Bex F; Hallez S
    Eur J Immunol; 2007 Feb; 37(2):376-84. PubMed ID: 17274002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a chicken viral Newcastle disease virus F gene-C3d fusion protein containing a chicken homologue of C3d.
    Liu D; Niu ZX
    Viral Immunol; 2008 Sep; 21(3):389-98. PubMed ID: 18788947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-specific antigens and the N-terminal fragment of gp96.
    Yan J; Liu X; Wang Y; Jiang X; Liu H; Wang M; Zhu X; Wu M; Tien P
    J Gene Med; 2007 Feb; 9(2):107-21. PubMed ID: 17256801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunogenicity of viral haemorragic septicaemia rhabdovirus (VHSV) DNA vaccines can depend on plasmid regulatory sequences.
    Chico V; Ortega-Villaizan M; Falco A; Tafalla C; Perez L; Coll JM; Estepa A
    Vaccine; 2009 Mar; 27(13):1938-48. PubMed ID: 19368775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
    Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
    J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro expression of Lgeionella pneumophila pilE gene and its immunogenicity].
    Yang ZW; Chen JP; Wang T; Tian Y; Liu DS
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):141-5. PubMed ID: 17355920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of plasmid DNA constructs for vaccines.
    Montgomery DL; Prather KJ
    Methods Mol Med; 2006; 127():11-22. PubMed ID: 16988443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced generation of cytotoxic T lymphocytes by increased cytosolic delivery of MHC class I epitope fused to mouse heat shock protein 70 via polyhistidine conjugation.
    Takemoto S; Nishikawa M; Otsuki T; Yamaoka A; Maeda K; Ota A; Takakura Y
    J Control Release; 2009 Apr; 135(1):11-8. PubMed ID: 19100299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion protein of ATPase domain of Hsc70 with TRP2 acting as a tumor vaccine against B16 melanoma.
    Zhang H; Wang W; Li Q; Huang W
    Immunol Lett; 2006 Jun; 105(2):167-73. PubMed ID: 16580737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.